Ncardia Information
Summary
Ncardia is a private company that has been in the industry for 8 years. The company currently specializes in the Biotechnology, Biotechnology areas. The position of the CEO is occupied by Stefan Braam. Its headquarters is located at Leiden, Other, NL. The number of employees ranges from 25 to 100. The annual revenue of Ncardia varies between 100K and 5.0M. Total funding of the company - $12.4M. To connect with Ncardia employee register on SignalHire.
Industries
Biotechnology
Headquarters Location
Employees Size
100-200 employees
Specialties
stem cells, ipsc, cardiomyocytes, neurons, drug discovery, drug development, cardiovascular safety, cardiovascular efficacy, neural safety, neural efficacy, CRO, fibroblast, astrocytes, electrophysiology, safety pharmacology, toxicology, assay development, contraction assays, custom cell lines, assay solutions, disease modeling, HTS, CMO
SIC Code
2836
Founded
2011
Estimated Annual Revenue
$100K - 5.0M
Operating Status
Independent Company
Competitors
Founded | Type | Employees | Revenue | Funding | |
|---|---|---|---|---|---|
| 2006 | Public Company | 1 - 25 | 16M | $153.7M | |
| 2004 | Public Company | 25 - 100 | < 1M | $37.8M | |
| 2025 | Privately Held | 1 - 25 | 3M | $10.4M | |
| 1993 | Public Company | 500 - 1.0K | 573.5M | $201M | |
| 2016 | Privately Held | 100 - 250 | 14.3M | $42M | |
| 1993 | Privately Held | 1.0K - 5.0K | 200M | $45M | |
| 2008 | Public Company | 25 - 100 | 5M | $350K | |
| 2016 | Privately Held | 25 - 100 | < 1M | $133M | |
| 1994 | Privately Held | 25 - 100 | 4.9M | $150K | |
| 1990 | - | 100-200 | - | $- | |
| 1995 | - | 200-500 | - | $- | |
| - | Public Company | 10-50 | - | $- | |
| 2005 | - | 100-200 | - | $- | |
| - | - | 200-500 | - | $- |
Employees Turnover 3 quarter 2025
Number of employees switched from or switched to
Length of Employment
